EUVIMEDEUVIMED entdecken
Crossref

Lubiprostone Induces Claudin-1 and Protects Intestinal Barrier Function

Norio Nishii, Tadayuki Oshima, Min Li, Hirotsugu Eda, Kumiko Nakamura, Akio Tamura, Tomohiro Ogawa, Takahisa Yamasaki, Takashi Kondo, Tomoaki Kono, Katsuyuki Tozawa, Toshihiko Tomita und 2 weitere

Pharmacology · 2020 · 105 (1-2) · 102-108

DOI: 10.1159/000503054 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacology, online erschienen am 19.09.2019. Verfasst von Norio Nishii und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan. Die Arbeit wurde bisher 31-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Lubiprostone, a chloride channel activator, is said to reduce epithelial permeability. However, whether lubiprostone has a direct effect on the epithelial barrier function and how it modulates the intestinal barrier function remain unknown. Therefore, the effects of lubiprostone on intestinal barrier function were evaluated in vitro.

Methods

Caco-2 cells were used to assess the intestinal barrier function. To examine the expression of claudins, immunoblotting was performed with specific antibodies. The effects of lubiprostone on cytokines (IFNγ, IL-6, and IL-1β) and aspirin-induced epithelial barrier disruption were assessed by transepithelial electrical resistance (TEER) and fluorescein isothiocyanate (FITC) labeled-dextran permeability.

Results

IFNγ, IL-6, IL-1β, and aspirin significantly decreased TEER and increased epithelial permeability. Lubiprostone significantly improved the IFNγ-induced decrease in TEER in a dose-dependent manner. Lubiprostone significantly reduced the IFNγ-induced increase in FITC labeled-dextran permeability. The changes induced by IL-6, IL-1β, and aspirin were not affected by lubiprostone. The expression of claudin-1, but not claudin-3, claudin-4, occludin, and ZO-1 was significantly increased by lubiprostone.

Conclusion

Lubiprostone significantly improved the IFNγ-induced decrease in TEER and increase in FITC labeled-dextran permeability. Lubiprostone increased the expression of claudin-1, and this increase may be related to the effect of lubiprostone on the epithelial barrier function.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Caco-2 CellsClaudin-1HumansInterferon-gammaIntestinal MucosaLubiprostone

Stichwörter der Autor:innen

Barrier functionClaudin-1CytokineInflammationIntestineTight junction

Substanzen

CLDN1 protein, humanClaudin-1LubiprostoneInterferon-gamma

Autor:innen und Institutionen

  • Division of Gastroenterology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.
  • Division of Gastroenterology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan, t-oshima@hyo-med.ac.jp.

Zitieren

APA

Nishii, N., Oshima, T., Li, M., Eda, H., Nakamura, K., Tamura, A., Ogawa, T., Yamasaki, T., Kondo, T., Kono, T., Tozawa, K., Tomita, T., Fukui, H., & Miwa, H. (2020). Lubiprostone Induces Claudin-1 and Protects Intestinal Barrier Function. Pharmacology, 105(1-2), 102-108. https://doi.org/10.1159/000503054

Vancouver

Nishii N, Oshima T, Li M, Eda H, Nakamura K, Tamura A, et al. Lubiprostone Induces Claudin-1 and Protects Intestinal Barrier Function. Pharmacology. 2020;105(1-2):102-108. doi:10.1159/000503054

BibTeX
@article{Nishii2020,
  author = {Nishii, Norio and Oshima, Tadayuki and Li, Min and Eda, Hirotsugu and Nakamura, Kumiko and Tamura, Akio and Ogawa, Tomohiro and Yamasaki, Takahisa and Kondo, Takashi and Kono, Tomoaki and Tozawa, Katsuyuki and Tomita, Toshihiko and Fukui, Hirokazu and Miwa, Hiroto},
  title = {Lubiprostone Induces Claudin-1 and Protects Intestinal Barrier Function},
  journal = {Pharmacology},
  year = {2020},
  volume = {105},
  number = {1-2},
  pages = {102--108},
  doi = {10.1159/000503054}
}
Kostenlos starten →